Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The progress test as a diagnostic tool for a new PBL curriculum.

Education for health (Abingdon, England)·2012
Same author

CT and barium features of gastrointestinal and peritoneal tuberculosis.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2009
Same author

Radiology quiz. Confirmed case of ulcerative colitis.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2009
Same author

Comparative study of plain abdominal films and small bowel enema in clinically unclear cases of small bowel obstruction.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2009
Same author

Strangulation of a small bowel loop caused by a defect in the broad ligament of the uterus.

Annals of Saudi medicine·2007
Same author

Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.

Cancer·2001

Related Experiment Video

Updated: May 9, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Breast inflammation in type 1 diabetes.

D Makanjuola1, A Al Kushi, M Al Zaid

  • 1Medical Imaging Department, King Abdulaziz Medical City, Riyadh KSA.

West African Journal of Medicine
|August 6, 2013
PubMed
Summary

Lymphocytic mastitis, a breast condition in diabetics, shows varied imaging. Follow-up reveals intense acoustic shadowing, suggesting type 1 diabetes in young women with breast abscess.

Area of Science:

  • Radiology
  • Endocrinology
  • Pathology

Background:

  • Lymphocytic mastitis is a rare fibroinflammatory breast condition associated with long-standing diabetes.
  • Imaging findings for lymphocytic mastitis can vary significantly across mammography, ultrasound, and MRI.
  • This study investigates imaging variations and presents cases of breast abscess as an initial manifestation of type 1 diabetes.

Observation:

  • The study included 13 women (ages 22-54) with pathologically confirmed lymphocytic mastopathy or breast abscess.
  • Clinical presentation varied from painless masses (lymphocytic mastitis) to painful masses (breast abscess), notably in young, non-lactating women.
  • Mammography commonly showed stromal distortion; ultrasound revealed initial stromal changes or mass-like lesions.

Findings:

More Related Videos

Staining Protocols for Human Pancreatic Islets
07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Related Experiment Videos

Last Updated: May 9, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Staining Protocols for Human Pancreatic Islets
07:48

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

  • Follow-up imaging (2-4 years) demonstrated interval development of dense acoustic shadowing without masses in all cases.
  • Complete resolution occurred in 40% of lymphocytic mastitis cases, with partial resolution in the rest.
  • Breast abscesses in young, non-lactating females may indicate type 1 diabetes.

Implications:

  • Understanding varied imaging patterns is crucial for diagnosing lymphocytic mastitis.
  • Persistent acoustic shadowing on ultrasound is a characteristic chronic change.
  • Breast abscesses in young, non-lactating women warrant investigation for type 1 diabetes.